• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

SPACs

Memic Innovative Surgery’s SPAC deal is off

March 10, 2022 By Chris Newmarker

Memic Innovative Surgery and the SPAC called MedTech Acquisition Corp. are calling off the merger that would have taken Memic public. The two companies said the decision was mutual — the result of market conditions and associated volatility due to recent world events. Memic is the developer of Hominis —  the first FDA-approved, robotically assisted […]

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions, News Well, Surgical, Surgical Robotics, Wall Street Beat Tagged With: MedTech Acquisition Corp., Memic Innovative Surgery, SPACs

Better Therapeutics closes SPAC merger, debuts on Nasdaq

October 29, 2021 By Sean Whooley

Better Therapeutics announced today that it completed its merger with Mountain Crest Acquisition Corp and has gone public on the Nasdaq. San Francisco-based Better Therapeutics announced its intention to merge with Mountain Crest, a publicly-traded, special purpose acquisition corporation (SPAC), in April. Last month, the company confirmed its expectations for the $113 million SPAC merger to go through […]

Filed Under: Business/Financial News, Diabetes, Digital Health, Drug-Device Combinations, Featured, Mergers & Acquisitions, Wall Street Beat Tagged With: Better Therapeutics, Mountain Crest SPAC, SPACs

LumiraDx goes public as SPAC deal closes

September 29, 2021 By Chris Newmarker

LumiraDx shares are trading at more than $8 apiece on the Nasdaq today under the symbol LMDX after the company completed its merger with a SPAC called CA Healthcare Acquisition Corp. The point of care diagnostic testing company has a pipeline of more than 30 assays across common health conditions, including infectious diseases, cardiovascular diseases, […]

Filed Under: Business/Financial News, Diagnostics, Digital Health, Featured, Funding Roundup, Initial Public Offering (IPO), Wall Street Beat Tagged With: LumiraDX, SPAC, SPACs

Vicarious Surgical stock continues to rise

September 21, 2021 By Chris Newmarker

It’s so far, so good for Vicarious Surgical (NYSE:RBOT) during its first week of trading as a public company. The robotic surgery company’s shares were up more than 19% to $15.05 by midday today. During the company’s first day of trading yesterday, shares rose 2% to $12.60 apiece, even as the Dow Jones Industrial Average […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Initial Public Offering (IPO), Surgical, Surgical Robotics, Wall Street Beat Tagged With: SPACs, Vicarious Surgical

Prenetics is going public through a SPAC deal

September 16, 2021 By Sean Whooley

Genomic and diagnostic testing company Prenetics announced that it will merge with Artisan Acquisition Corp. and go public. Artisan, a special purpose acquisition company (SPAC), will provide a business portfolio across retail, hospitality, healthcare, property and other strategic businesses for Prenetics to substantially expand its platform through the merger, according to a news release. The […]

Filed Under: Business/Financial News, Diagnostics, Featured, Genomics/Molecular Diagnostics, Mergers & Acquisitions, Wall Street Beat Tagged With: Artisan Acquisition Corp., coronavirus, COVID-19, Prenetics, SPAC, SPACs

Memic Innovative Surgery to go public via SPAC merger

August 13, 2021 By Sean Whooley

Memic Innovative Surgery announced that it entered into a merger agreement with special purpose acquisition company MedTech Acquisition Corp. Tel Aviv, Israel-based Memic will operate under its current name upon the closing of the transaction, with Dr. Maurice R. Ferré — an independent director of MedTech and current chairman of Memic — will serve as […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Gynecological, Initial Public Offering (IPO), Mergers & Acquisitions, Surgical, Surgical Robotics, Wall Street Beat, Women's Health Tagged With: Dr. Maurice R. Ferré, MedTech Acquisition Corp., Memic Innovative Surgery, SPACs

Pear Therapeutics to go public via SPAC merger

June 22, 2021 By Sean Whooley

Prescription digital therapeutics pioneer Pear Therapeutics announced today that it will go public by merging with a SPAC called Thimble Point Acquisition Corp. Boston-based Pear Therapeutics’ combination with the special purpose acquisition company (SPAC), whose management team is associated with the Pritzker Vlock Family Office, will result in a combined company named Pear Holdings Corp. […]

Filed Under: Business/Financial News, Digital Health, Drug-Device Combinations, Featured, Funding Roundup, Health Technology, Initial Public Offering (IPO), Mergers & Acquisitions, Neurological, Patient Monitoring, Pharmaceutical, Software / IT, Wall Street Beat Tagged With: Pear Therapeutics, SPACs, Thimble Point Acquisition Corp.

Memic may go public through merger with SPAC

May 19, 2021 By Sean Whooley

Memic Innovative Surgery is reportedly eyeing a move to go public through a merger with SPAC MedTech Acquisition Corp. Bloomberg reported that people with knowledge of the matter say that Memic, which develops Hominis, the first FDA-approved, robotically assisted surgical device for performing transvaginal hysterectomy, is in talks over going public with the SPAC. A […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Gynecological, Initial Public Offering (IPO), Mergers & Acquisitions, Surgical, Surgical Robotics, Wall Street Beat, Women's Health Tagged With: MedTech Acquisition Corp., Memic Innovative Surgery, SPACs

Vicarious Surgical to go public in $1.1B SPAC deal

April 15, 2021 By Chris Newmarker

Vicarious Surgical will go public through a $1.1 billion special purpose acquisition company (SPAC) deal, the robotic surgery pioneer announced today. Vicarious, which has sought to bring robotics and virtual reality to minimally invasive surgery, will trade on the New York Stock Exchange under the symbol RBOT after the merger with D8 Holdings. Hong Kong–based […]

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions, Surgical, Surgical Robotics Tagged With: BD, D8 Holdings, robot-assisted, Robotic Surgery, SPACs, Vicarious Surgical

Former Verb Surgical CEO has a medtech SPAC, planning a $175M IPO

February 22, 2021 By Chris Newmarker

A group of medical device industry insiders — including former Verb Surgical and Volcano Corp. CEO Scott Huennekens  — is planning a $175 million IPO for a special purpose acquisition company (SPAC). Los Angeles–based VIDA FLaSH Acquisitions filed a form S-1 with the U.S. Securities and Exchange Commission on Feb. 18 for a proposed IPO […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Initial Public Offering (IPO) Tagged With: Compute Health Acquisition, MedTech Acquisition Corp., SPACs, VIDA FLaSH Acquisitions

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy